DHAI vs MBOT vs BWAY vs LFMD vs ENVA

For growth investors, BrainsWay Ltd.

(BWAY) is the stronger pick with 28. 3% revenue growth year-over-year, versus -8. 7% for LifeMD, Inc. (LFMD). Enova International, Inc. (ENVA) offers the better valuation at 14. 9x trailing P/E (10. 5x forward), making it the more compelling value choice. Analysts rate Microbot Medical Inc. (MBOT) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Enova International, Inc.

(ENVA) is the cheapest at 14. 9x versus BrainsWay Ltd. at 46. 4x. On forward P/E, Enova International, Inc. is actually cheaper at 10. 5x.

Over the past 5 years, Enova International, Inc.

(ENVA) delivered a total return of +368. 1%, compared to -99. 9% for DIH Holding US, Inc. (DHAI). Over 10 years, the gap is even starker: ENVA returned +20. 3% versus DHAI's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), DIH Holding US, Inc.

(DHAI) is the lower-risk stock at -1. 13β versus LifeMD, Inc. 's 2. 12β — meaning LFMD is approximately -289% more volatile than DHAI relative to the S&P 500. On balance sheet safety, Microbot Medical Inc. (MBOT) carries a lower debt/equity ratio of 3% versus 3% for Enova International, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), BrainsWay Ltd.

(BWAY) is pulling ahead at 28. 3% versus -8. 7% for LifeMD, Inc. (LFMD). On earnings-per-share growth, the picture is similar: BrainsWay Ltd. grew EPS 300. 0% year-over-year, compared to 24. 1% for DIH Holding US, Inc.. Over a 3-year CAGR, BWAY leads at 24. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

BrainsWay Ltd.

(BWAY) is the more profitable company, earning 14. 6% net margin versus -13. 8% for DIH Holding US, Inc. — meaning it keeps 14. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ENVA leads at 23. 5% versus -7. 7% for DHAI. At the gross margin level — before operating expenses — LFMD leads at 79. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Enova International, Inc.

(ENVA) trades at 10. 5x forward P/E versus 85. 7x for BrainsWay Ltd. — 75. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MBOT: 158. 2% to $5. 50.

In this comparison, LFMD (1.

5% yield) pays a dividend. DHAI, MBOT, BWAY, ENVA do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, DIH Holding US, Inc.

(DHAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -1. 13)). Microbot Medical Inc. (MBOT) carries a higher beta of 1. 85 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DHAI: -99. 9%, MBOT: -99. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (DHAI (Healthcare) and MBOT (Healthcare) and BWAY (Healthcare) and LFMD (Healthcare) and ENVA (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: DHAI is a small-cap quality compounder stock; MBOT is a small-cap quality compounder stock; BWAY is a small-cap high-growth stock; LFMD is a small-cap quality compounder stock; ENVA is a small-cap high-growth stock. LFMD pays a dividend while DHAI, MBOT, BWAY, ENVA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.